Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |